| Authors: |
Wilson LJ; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Linley A; Department of Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Hammond DE; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Hood FE; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Coulson JM; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., MacEwan DJ; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Ross SJ; AstraZeneca, Cambridge Biomedical Campus, Cambridge, United Kingdom., Slupsky JR; Department of Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Smith PD; AstraZeneca, Cambridge Biomedical Campus, Cambridge, United Kingdom., Eyers PA; Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Prior IA; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. iprior@liverpool.ac.uk. |